SB066

Regulation of Compounded Weight-Loss Medication

Failed·5/5/26

Colorado SB066 regulates the sale and distribution of compounded weight-loss medications, requiring compliance with FDA standards and prohibiting.

Colorado SB066 establishes regulations for the sale, transfer, or distribution of compounded weight-loss medications, which are custom-made medications not subject to FDA approval. The bill mandates that these medications must be made from FDA-approved bulk drug substances and manufactured in compliance with FDA processes. It requires sellers to maintain records related to the acquisition and testing of these substances for at least two years.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Sponsors

DD
2
1
R
Democratic CaucusRepublican Caucus

Roll Call Votes

12 Yea

RRRRDDDDDDRD

0 Nay

1 Absent

D

Calendar

May 5

12:00 AM

House Health & Human Services Hearing

Apr 17

7:30 AM

Senate Third Reading Calendar

History

May 5

House

House Committee on Health & Human Services Postpone Indefinitely

Apr 20

House

Introduced In House - Assigned to Health & Human Services

Apr 17

Senate

Senate Third Reading Passed with Amendments - Floor